Literature DB >> 31585816

Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis.

Ho Suk Kang1, Mi Jung Kwon2, Tae-Hwan Kim3, Junhee Han4, Young-Su Ju5.   

Abstract

Because rectal neuroendocrine tumors (NETs) are usually small-sized despite of malignant potential, endoscopic resection techniques are recommended. It is unclear whether the lymphovascular invasion (LVI) in the endoscopic resected specimens of small rectal NETs should be indicated for completion surgery. We performed a systematic review and meta-analysis for the incidence of LVI in small rectal NETs (≤20 mm) treated by endoscopic resection and its prognostic impacts. We searched the relevant literature published before January 2019. A total of 21 publications including 1816 patients were enrolled. Overall prevalence of LVI in small rectal NETs was 21.8%. Immunohistochemical method significantly increased the detection rate of LVI up to 35.8% compared than H&E staining only (13.2%). Tumor size more than 5 mm was a risk factor for LVI in small rectal NET, whereas tumor grade did not influence the risk. The LVI in the endoscopic resected specimens was a risk factor for subsequent lymph node metastasis. Separately analyzed in detail, the vascular invasion had a stronger impact on lymph node metastasis than the lymphatic invasion. The prognosis of endoscopically treated rectal NET with LVI was excellent with only 0.3% of recurrence rate during the 5-year follow-up period. LVI is highly prevalent and a risk factor for lymph node metastasis in the small rectal NETs. Endoscopically treated small rectal NETs had excellent short-term prognoses despite of LVI. Immediate completion radical surgery is not absolutely necessary for the LVI-positive small rectal NETs. However, long-term follow-up is recommended for any delayed recurrence.
Copyright © 2019 The Authors. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Keywords:  Carcinoid; Endoscopic resection; Lymph node metastasis; Lymphovascular invasion; Meta-analysis; Neuroendocrine; Prognosis

Mesh:

Year:  2019        PMID: 31585816     DOI: 10.1016/j.prp.2019.152642

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

1.  Prognosis of rectal neuroendocrine tumors after endoscopic resection: a single-center retrospective study.

Authors:  Yue Zheng; Kehang Guo; Ruijie Zeng; Zhendao Chen; Wanwei Liu; Xiaoguang Zhang; Weimin Liang; Jianhua Liu; Hao Chen; Weihong Sha
Journal:  J Gastrointest Oncol       Date:  2021-12

2.  Comparison between endoscopic mucosal resection with a cap and endoscopic submucosal dissection for rectal neuroendocrine tumors.

Authors:  Xiuli Zheng; Mingli Wu; Huihui Shi; Limian Er; Kan Wang; Ying Cao; Shengmian Li
Journal:  BMC Surg       Date:  2022-06-27       Impact factor: 2.030

Review 3.  Diagnosis and Management of Rectal Neuroendocrine Tumors (NETs).

Authors:  Francesco Maione; Alessia Chini; Marco Milone; Nicola Gennarelli; Michele Manigrasso; Rosa Maione; Gianluca Cassese; Gianluca Pagano; Francesca Paola Tropeano; Gaetano Luglio; Giovanni Domenico De Palma
Journal:  Diagnostics (Basel)       Date:  2021-04-25

4.  A nationwide, multi-institutional collaborative retrospective study of colorectal neuroendocrine tumors in Japan.

Authors:  Tatsuro Yamaguchi; Keiichi Takahashi; Kazutaka Yamada; Hiroyuki Bando; Hideo Baba; Masaaki Ito; Kimihiko Funahashi; Hideki Ueno; Shin Fujita; Seiji Hasegawa; Yoshiharu Sakai; Kenichi Sugihara
Journal:  Ann Gastroenterol Surg       Date:  2020-11-17

5.  Risk Factors Associated with the Development of Metastases in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Retrospective Analysis.

Authors:  Shuzo Kohno; Masahiro Ikegami; Toru Ikegami; Hiroaki Aoki; Masaichi Ogawa; Fumiaki Yano; Ken Eto
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

6.  Risk factors for lymph node metastasis and prognosis in colorectal neuroendocrine tumours.

Authors:  Xiuli Zheng; Mingli Wu; Limian Er; Huiyan Deng; Gongning Wang; Lingyao Jin; Shengmian Li
Journal:  Int J Colorectal Dis       Date:  2022-01-08       Impact factor: 2.571

7.  Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study.

Authors:  Angela Dalia Ricci; Sara Pusceddu; Francesco Panzuto; Fabio Gelsomino; Sara Massironi; Claudio Giovanni De Angelis; Roberta Modica; Gianluca Ricco; Martina Torchio; Maria Rinzivillo; Natalie Prinzi; Felice Rizzi; Giuseppe Lamberti; Davide Campana
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

8.  Risk Factors for Lymph Node Metastasis and Oncologic Outcomes in Small Rectal Neuroendocrine Tumors with Lymphovascular Invasion.

Authors:  Seung-Joo Nam; Byung Chang Kim; Hee Jin Chang; Han Ho Jeon; Junho Kim; Su Young Kim
Journal:  Gut Liver       Date:  2022-03-15       Impact factor: 4.519

9.  Prognostic significance for colorectal carcinoid tumors based on the 8th edition TNM staging system.

Authors:  Piqing Gong; Chunhua Chen; Zhan Wang; Xukun Zhang; Wenxin Hu; Zhiqian Hu; Xinxing Li
Journal:  Cancer Med       Date:  2020-09-08       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.